Clinical and prognostic analysis of hepatitis B virus infection in diffuse large B-cell lymphoma.
about
Hepatitis C virus reactivation in cancer patients in the era of targeted therapies.Malignancy in systemic lupus erythematosus: what have we learned?Concurrent infection of hepatitis B virus negatively affects the clinical outcome and prognosis of patients with non-Hodgkin's lymphoma after chemotherapyRituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reportsChronic hepatitis virus infection in patients with multiple myeloma: clinical characteristics and outcomes.Epidemiologic overview of malignant lymphoma.Rituximab plus chemotherapy as first-line treatment in Chinese patients with diffuse large B-cell lymphoma in routine practice: a prospective, multicentre, non-interventional studyHepatitis B virus-associated diffuse large B-cell lymphoma: unique clinical features, poor outcome, and hepatitis B surface antigen-driven origin.New developments in the pathology of malignant lymphoma: a review of the literature published from May to July 2008The late adverse events of rituximab therapy--rare but there!The association of hepatitis B virus infection with B-cell non-Hodgkin lymphoma - a review.A drug safety evaluation of rituximab and risk of hepatitis B.Management of patients with overt or resolved hepatitis B virus infection undergoing rituximab therapy.Risk and prophylaxis strategy of hepatitis B virus reactivation in patients with lymphoma undergoing chemotherapy with or without rituximab.Hepatitis B reactivation in patients receiving targeted therapies.Hepatitis B virus infection is associated with younger median age at diagnosis and death in cancers.High prevalence of diffuse large B-cell lymphoma in occult hepatitis B virus-infected patients in the Tohoku district in Eastern Japan.Clinical analysis and prognostic significance of hepatitis B virus infections for diffuse large B-cell lymphoma with or without rituximab therapy.HBsAg is an independent prognostic factor in diffuse large B cell lymphoma patients in rituximab era: result from a multicenter retrospective analysis in China.Prognostic value of chronic hepatitis B virus infection in patients with nasopharyngeal carcinoma: analysis of 1301 patients from an endemic area in China.Prognostic analysis of acute exacerbations of hepatitis-B after chemotherapy in combination with rituximab in 19 patients with lymphoma.Relationships between hepatitis B infection status and liver dysfunction after chemotherapy of lung cancer patients in mainland China.Efficacy of prophylactic lamivudine to prevent hepatitis B virus reactivation in B-cell lymphoma treated with rituximab-containing chemotherapy.
P2860
Q33735212-51BFDE7A-DB9B-4974-9946-0AC807669AD2Q34087859-111AC4C6-30CB-4F7D-B7FA-A71787774847Q34828556-F514F6CA-2FF3-499E-A7D5-03AC1BDF0D7AQ34854165-26463C44-98CE-4BCE-9040-609D44E8B8D5Q35580212-9D2BD40B-6712-4F61-813B-EE1404E57717Q36074055-941003F7-3742-41B8-B5FC-B36736AD30DFQ36086520-9DF8DFB0-C1BE-4A7E-BB15-A8ECD30A31D5Q36413119-B7877129-BD47-40FB-8CD5-115CF323A67CQ37268997-F5A47EA4-3B83-41D7-B605-70277EA8DB8AQ37462485-1654CA50-B6B2-4F3D-AAA8-9A2E9255C903Q37995199-B610E8F9-1A88-4853-8AEA-684E8345D74FQ38211373-1293E2EB-0FB0-47B8-B64C-18B29C51CE26Q38218566-2C5CC4FC-C215-4440-A18B-37A234E67CC3Q38253568-673BCAB1-8530-4017-BFA8-EA38FE81A37FQ39293427-41DBEB79-7C3E-431F-A7A3-B542C09C1DB7Q40261539-E3BF64AD-BD90-4C7F-ACCE-30B0BA47E227Q40661783-DE7FD94B-81E4-40CC-BDC7-4EC50F28FFFBQ42121505-46BA7630-CD57-49DC-B7FB-209FC54DEA84Q42240670-D53FC470-A4B4-4237-99A8-DD516746B551Q42263472-9D3DFE6F-E6A2-44A3-AA04-36849EEFDCE5Q42921297-04B6CEB8-1C76-446B-B6FC-DA37B2B24EECQ44366710-CC181E48-0BB8-4983-B9FC-2E3708D0DC99Q45353928-88C72822-517C-470D-86DB-E4CC0E06CCF2
P2860
Clinical and prognostic analysis of hepatitis B virus infection in diffuse large B-cell lymphoma.
description
2008 nî lūn-bûn
@nan
2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Clinical and prognostic analys ...... diffuse large B-cell lymphoma.
@ast
Clinical and prognostic analys ...... diffuse large B-cell lymphoma.
@en
Clinical and prognostic analys ...... diffuse large B-cell lymphoma.
@nl
type
label
Clinical and prognostic analys ...... diffuse large B-cell lymphoma.
@ast
Clinical and prognostic analys ...... diffuse large B-cell lymphoma.
@en
Clinical and prognostic analys ...... diffuse large B-cell lymphoma.
@nl
prefLabel
Clinical and prognostic analys ...... diffuse large B-cell lymphoma.
@ast
Clinical and prognostic analys ...... diffuse large B-cell lymphoma.
@en
Clinical and prognostic analys ...... diffuse large B-cell lymphoma.
@nl
P2093
P2860
P356
P1433
P1476
Clinical and prognostic analys ...... diffuse large B-cell lymphoma
@en
P2093
Dong-shen Zhang
Hui-qiang Huang
Hui-yan Luo
Wen-qi Jiang
Xiao-fei Sun
Zhong-jun Xia
Zhong-zhen Guan
P2860
P2888
P356
10.1186/1471-2407-8-115
P407
P50
P577
2008-04-23T00:00:00Z
P5875
P6179
1049554279